Senior Analyst - Forecasting Rare Disease; Global

Job Title – Senior Analyst - Forecasting Rare Disease (Global)

• Career Level – D1
• Location:
  
  Manyata Tech Park, Bangalore
• Shift: 2 PM
  -11 PM IST, Hybrid (3 days a week in office)
• Total Experience required: 7 to 10 years.

Alexion, AstraZeneca Rare Disease is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Alexion is the global leader in complement inhibition and has developed and markets Soliris® (eculizumab) as a treatment for patients with PNH and aHUS, two debilitating, ultra-rare and life‑threatening disorders caused by chronic uncontrolled complement activation.

Soliris is currently approved in more than 40 countries for the treatment of PNH, and in the United States and European Union for the treatment of aHUS. Alexion is evaluating other potential indications for Soliris and is pursuing development of other innovative biotechnology product candidates in early stages of development. Further information about Alexion Pharmaceuticals, Inc. can be found at:

The Forecast Senior Analyst works closely with the GIBEx/ GA&I Forecast Leader, Portfolio Heads and Commercial teams to develop brand forecasts (revenue, volume and patients) for strategic brands and / or early assets for Global (focus on Top 8 markets) or US. As a Forecast Analyst, you will play a meaningful role in this process, understanding the assigned therapeutic area and brand, setting expectations for performance and helping guide brand strategy.

Together with the Forecast Leader/Portfolio Head, the Forecast Analyst develops robust portfolio forecasting and reporting model/dashboard to define financial opportunities across indications/therapeutic areas for the pipeline which aid in enterprise‑wide portfolio decision making. This position will support assessment of internal and external opportunities, including rationale, technical and commercial considerations, in partnership with key organization stakeholders including GIBEx/ GA&I, Marketing, Sales, Market Access and Pricing, Finance and Sales Operations.

As such, the ideal candidate is highly collaborative and confident working with senior and middle management. This includes Global Program Leaders and their groups, regional Commercial management, and Therapeutic Area management and their teams during internal governance interactions.

The key focus of this role is to provide financial and analytical support and oversight and produce long‑term topline and patient forecasting to enable data‑driven decision making (integrated with market insights), demand and infrastructure planning, and deeper comprehension of underlying commercial opportunities. This work will include the development of strategic cases, scenarios, and inputs into portfolio prioritization.

• Responsible for the timely delivery of robust and transparent demand forecasts across multiple indications for strategic brands / therapy areas and key markets, including clear documentation of assumptions as well as levels of confidence / robustness
• Support annual processes related to portfolio assessment, long‑term, mid‑term planning & beyond mid‑term for in‑line products, planning, management, and prioritization for portfolios like rare disease, OBU etc. including analyzing changes with respect to prior evaluations.
• Actively participate & facilitate cross‑functional discussions at program and portfolio level to influence program level strategic and forecasting discussions, provide portfolio view and cross‑product knowledge, and generate alignment on company long‑term strategic plans
• Expertly defend forecast approach, methodology, assumptions and output to cross‑functional teams
• Ensure objectivity and robustness in the forecast by identifying the right information channels. Apply industry‑leading modelling approaches with sensitivity analyses around key variables. This helps manage opportunities and risks.
• Demonstrate a high level of understanding of the points of integration of our work and that of our colleagues.
• Dev…